0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Intravesical immunoprophylaxis in recurrent superficial bladder cancer (stage T1): Multicenter trial comparing bacille calmette-guérin and interferon-alpha

      , , , , , , ,
      Urology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To estimate and compare recurrence rates, index of recurrence, and disease-free interval in patients with superficial recurrent bladder cancer receiving bacille Calmette-Guérin (BCG) or interferon (IFN) for immunoprophylaxis.

          Related collections

          Author and article information

          Journal
          Urology
          Urology
          Elsevier BV
          00904295
          October 1997
          October 1997
          : 50
          : 4
          : 529-535
          Article
          10.1016/S0090-4295(97)00303-8
          9338727
          da4b2ee1-43b7-4293-975a-7e78bd406b6f
          © 1997

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article